Shattuck Labs, Inc. (STTK): Shareholders' Equity
$82.39M
As of 2025-12-31
$211.14M
As of 2026-06-30
-22.4%
3-year compound annual growth
-23.3%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $82.39M | +3.5% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $79.63M | -45.0% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $144.71M | -17.9% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $176.16M | -35.2% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $271.79M | -12.3% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $309.86M | n/m | 2022-03-15, Balance as of period end |
| 2019-12-31 | -$34.55M | n/a | 2021-03-16, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $82.39M | +3.5% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $3.46M | -14.2% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $2.84M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $98.37M | +14.0% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$2.09M | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $29.71M | +92.4% |
| Rallybio Corp (RLYB) | 2025-12-31 | $57.96M | -6.0% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $24.60M | +29.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $5.67M | -74.1% |
Compare STTK, SXTP, DARE, RFL side by side · Screen every company in Pharmaceutical Preparations ↗